Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 -0.07 (-3.63%) Market Cap: 568.03 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.17 GF Score: 55/100

Q4 2023 Pacific Biosciences of California Inc Earnings Call Transcript

Feb 15, 2024 / 10:00PM GMT
Release Date Price: $6.67 (+2.62%)
Operator

Hello, and welcome to the PacBio Fourth Quarter 2023 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask Quest. If you ask a question, you may press star then one on your telephone keypad. And to withdraw from the question queue, please press star then two. I would now like to hand the call to Todd Friedman, Senior Director, Investor Relations.

Please go ahead.

Todd Friedman
Pacific Biosciences of California, Inc. - IR

Good afternoon, and welcome to PacBio Fourth Quarter 2023 earnings conference call. Earlier today, we issued a press release outlining the financial results we will be discussing on today's call a copy of which is available on the Investors section of our website at www.pacv.com for us furnished on Form eight K available on the Securities and Exchange Commission website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot